{"id":1113,"date":"2023-01-01T00:00:03","date_gmt":"2022-12-31T23:00:03","guid":{"rendered":"https:\/\/emanuelabottanilab.it\/?post_type=pubblicazioni&#038;p=1113"},"modified":"2025-11-10T10:52:36","modified_gmt":"2025-11-10T09:52:36","slug":"ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients","status":"publish","type":"pubblicazioni","link":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/","title":{"rendered":"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients"},"template":"","meta":{"_gspb_post_css":""},"class_list":["post-1113","pubblicazioni","type-pubblicazioni","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab\" \/>\n<meta property=\"og:url\" content=\"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Emanuela Bottani Lab\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-10T09:52:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/emanuelabottanilab.it\/cms\/wp-content\/uploads\/2025\/09\/logo_mitogen_dark-scaled.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"991\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/pubblicazioni\\\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\\\/\",\"url\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/pubblicazioni\\\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\\\/\",\"name\":\"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#website\"},\"datePublished\":\"2022-12-31T23:00:03+00:00\",\"dateModified\":\"2025-11-10T09:52:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/pubblicazioni\\\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/pubblicazioni\\\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/pubblicazioni\\\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/\",\"name\":\"Emanuela Bottani Lab\",\"description\":\"FUELING THE FUTURE OF RARE DISEASE CARE\",\"publisher\":{\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#organization\",\"name\":\"Emanuela Bottani Lab\",\"url\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/emanuelabottanilab.it\\\/cms\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/logo_mitogen_dark-scaled.png\",\"contentUrl\":\"https:\\\/\\\/emanuelabottanilab.it\\\/cms\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/logo_mitogen_dark-scaled.png\",\"width\":2560,\"height\":991,\"caption\":\"Emanuela Bottani Lab\"},\"image\":{\"@id\":\"https:\\\/\\\/emanuelabottanilab.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/","og_locale":"en_US","og_type":"article","og_title":"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab","og_url":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/","og_site_name":"Emanuela Bottani Lab","article_modified_time":"2025-11-10T09:52:36+00:00","og_image":[{"width":2560,"height":991,"url":"https:\/\/emanuelabottanilab.it\/cms\/wp-content\/uploads\/2025\/09\/logo_mitogen_dark-scaled.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/","url":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/","name":"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients - Emanuela Bottani Lab","isPartOf":{"@id":"https:\/\/emanuelabottanilab.it\/en\/#website"},"datePublished":"2022-12-31T23:00:03+00:00","dateModified":"2025-11-10T09:52:36+00:00","breadcrumb":{"@id":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/emanuelabottanilab.it\/en\/pubblicazioni\/ppar-gamma-agonist-pioglitazone-recovers-mitochondrial-quality-control-in-fibroblasts-from-pitrm1-deficient-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/emanuelabottanilab.it\/en\/"},{"@type":"ListItem","position":2,"name":"PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients"}]},{"@type":"WebSite","@id":"https:\/\/emanuelabottanilab.it\/en\/#website","url":"https:\/\/emanuelabottanilab.it\/en\/","name":"Emanuela Bottani Lab","description":"FUELING THE FUTURE OF RARE DISEASE CARE","publisher":{"@id":"https:\/\/emanuelabottanilab.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/emanuelabottanilab.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/emanuelabottanilab.it\/en\/#organization","name":"Emanuela Bottani Lab","url":"https:\/\/emanuelabottanilab.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/emanuelabottanilab.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/emanuelabottanilab.it\/cms\/wp-content\/uploads\/2025\/09\/logo_mitogen_dark-scaled.png","contentUrl":"https:\/\/emanuelabottanilab.it\/cms\/wp-content\/uploads\/2025\/09\/logo_mitogen_dark-scaled.png","width":2560,"height":991,"caption":"Emanuela Bottani Lab"},"image":{"@id":"https:\/\/emanuelabottanilab.it\/en\/#\/schema\/logo\/image\/"}}]}},"meta_box":{"descrizione_pubblicazione":"Di Donfrancesco A, Berlingieri C, Giacomello M, Frascarelli C, Magalhaes Rebelo AP, Bindoff LA, Reeval S, Renbaum P, Santorelli FM, Massaro G, Viscomi C, Zeviani M, Ghezzi D, Bottani E, Brunetti D.Front Pharmacol. 2023","url_pubblicazione":"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2023.1220620\/full"},"_links":{"self":[{"href":"https:\/\/emanuelabottanilab.it\/en\/wp-json\/wp\/v2\/pubblicazioni\/1113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/emanuelabottanilab.it\/en\/wp-json\/wp\/v2\/pubblicazioni"}],"about":[{"href":"https:\/\/emanuelabottanilab.it\/en\/wp-json\/wp\/v2\/types\/pubblicazioni"}],"wp:attachment":[{"href":"https:\/\/emanuelabottanilab.it\/en\/wp-json\/wp\/v2\/media?parent=1113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}